Article Details

Boston Scientific enters renal denervation market with acquisition worth up to $540M

Retrieved on: 2025-03-03 22:43:33

Tags for this article:

Click the tags to see associated articles and topics

Boston Scientific enters renal denervation market with acquisition worth up to $540M. View article details on hiswai:

Excerpt

... technology is being embraced by healthcare provider and policymakers alike. ... HeartBeam raising $10M for FDA-cleared health tech with public offering ...

Article found on: cardiovascularbusiness.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo